NanoViricides Inc (NNVC):企業の財務・戦略的SWOT分析

【英語タイトル】NanoViricides Inc (NNVC) - Financial and Strategic SWOT Analysis Review

GlobalDataが出版した調査資料(DATA904C14864)・商品コード:DATA904C14864
・発行会社(調査会社):GlobalData
・発行日:2019年3月
・ページ数:25
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥32,700見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥65,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥98,100見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
NanoViricides Inc (NanoViricides) is a nano-biopharmaceutical company that discovers, develops and commercializes therapeutics to advance the care of patients suffering from life-threatening viral infections. The company offers nanoviricide drug candidates against epidemic influenzas and bird flu, HIV/AIDS, cold sores and genital herpes infection, viral eye diseases, and dengue viruses. NanoViricides provides skin cream from the treatment of shingles caused by aka varicella-zoster virus; skin cream for the treatment of orolabial herpes and recurrent herpes labialis (RHL) caused by herpes simplex virus type 1; ocular eye drops treatment for external eye herpes keratitis (HK), caused by HSV-1 or herpes simplex virus type 2 (HSV-2), skin cream for the treatment of genital herpes caused by HSV2, and others. It conducts research in the areas of medical science and pharmaceutical technology. NanoViricides is headquartered in Shelton, Connecticut, the US.

NanoViricides Inc Key Recent Developments

Mar 05,2019: NanoViricides Reports Excellent Safety Profile of Its First Drug Candidate in Dermal Treatment Study
Feb 19,2019: NanoViricides files quarterly report for period ending December 31, 2018 – HerpeCide drug candidate progressing in IND-enabling studies towards clinical trials
Feb 11,2019: NanoViricides President Dr. Diwan to present at the BIO CEO & Investor 2019 Event in New York City Tomorrow Feb 12th at 2:30pm
Jan 02,2019: NanoViricides CEO Dr. Taraporewala to present At The Biotech Showcase Investment Conference In San Francisco on January 7, 2019
Oct 29,2018: NanoViricides names Mr. James Sapirstein as Board Director

This comprehensive SWOT profile of NanoViricides Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of NanoViricides Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

NanoViricides Inc – Key Information
NanoViricides Inc – Overview
NanoViricides Inc – Key Employees
NanoViricides Inc – Key Employee Biographies
NanoViricides Inc – Key Operational Heads
NanoViricides Inc – Major Products and Services
NanoViricides Inc – History
NanoViricides Inc – Company Statement
NanoViricides Inc – Locations And Subsidiaries
NanoViricides Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

NanoViricides Inc – Business Description
NanoViricides Inc – Corporate Strategy
NanoViricides Inc – SWOT Analysis
SWOT Analysis – Overview
NanoViricides Inc – Strengths
NanoViricides Inc – Weaknesses
NanoViricides Inc – Opportunities
NanoViricides Inc – Threats
NanoViricides Inc – Key Competitors

Section 3 – Company Financial Performance Charts

NanoViricides Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

NanoViricides Inc, Key Information
NanoViricides Inc, Key Ratios
NanoViricides Inc, Share Data
NanoViricides Inc, Major Products and Services
NanoViricides Inc, History
NanoViricides Inc, Key Employees
NanoViricides Inc, Key Employee Biographies
NanoViricides Inc, Key Operational Heads
NanoViricides Inc, Other Locations
NanoViricides Inc, Subsidiaries
NanoViricides Inc, Key Manufacturing facilities
NanoViricides Inc, Key Competitors
NanoViricides Inc, SWOT Analysis
NanoViricides Inc, Ratios based on current share price
NanoViricides Inc, Annual Ratios
NanoViricides Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

NanoViricides Inc, Performance Chart
NanoViricides Inc, Ratio Charts

★調査レポート[NanoViricides Inc (NNVC):企業の財務・戦略的SWOT分析] (コード:DATA904C14864)販売に関する免責事項を必ずご確認ください。
★調査レポート[NanoViricides Inc (NNVC):企業の財務・戦略的SWOT分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆